Key result
Reduced mitral annular plane systolic excursion (MAPSE) independently predicted left ventricular diastolic dysfunction in patients with chronic kidney disease (OR 0.39; 95% CI 0.21-0.74; p=0.003).
Why the study?
Does reduced MAPSE predict left ventricular diastolic dysfunction in patients with stage 3-5 chronic kidney disease?
Observational (n=96)
Does reduced MAPSE predict left ventricular diastolic dysfunction in patients with stage 3-5 chronic kidney disease?
Reduced mitral annular plane systolic excursion (MAPSE) is an independent predictor of left ventricular diastolic dysfunction in patients with advanced chronic kidney disease.
Answers are grounded in this paper and cite their sources.
MAPSE may aid diastolic dysfunction detection in advanced CKD; hypothesis-generating and requires prospective validation.
BACKGROUND: Left ventricular (LV) diastolic dysfunction in chronic kidney disease (CKD) patients frequently leads to the development of congestive heart failure. We evaluated changes in echocardiographic parameters among CKD patients with LV diastolic dysfunction. METHODS: We examined 70 ambulatory patients with CKD at stages 3-5 and 26 patients without CKD as a control group. Standard echocardiography and tissue Doppler imaging were performed on all patients. Patients with CKD were divided into two groups according to the results of lateral mitral early diastolic velocity (EmLVlat): a group with diastolic dysfunction (DD group; EmLVlat <8 cm/s) and a group without diastolic dysfunction (WDD group; EmLVlat ≥8 cm/s). RESULTS: Compared to the patients in the WDD group, those in the DD group were characterized by lower values of mitral annular plane systolic excursion [MAPSE; 13 (11-17) vs. 14 (11-16) mm, p < 0.0001] and lateral mitral annular systolic velocity [SmLVlat; 7 (5-14) vs. 8 (5-13) cm/s, p = 0.006]. The area under the receiver operating characteristic (ROC) curve of the MAPSE level for the detection of LV diastolic dysfunction was 0.801 [95% CI 0.684-0.890, p < 0.0001], whereas a ROC-derived MAPSE value of ≤13 mm was characterized by a sensitivity of 84.4% and a specificity of 75.8% for diagnosing LV diastolic dysfunction. The only independent variable predicting LV diastolic dysfunction was MAPSE [OR = 0.39; 95% CI 0.21-0.74, p = 0.003]. CONCLUSION: We showed that reduced MAPSE, but not SmLVlat, is an independent predictive factor for LV diastolic dysfunction in CKD patients.
No takes yet. Share an insight, caveat, or question.
Gromadziński et al. (2014) conducted an observational in Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction (n=96). Mitral annular plane systolic excursion (MAPSE) was evaluated on Prediction of left ventricular diastolic dysfunction (OR 0.39, 95% CI 0.21-0.74, p=0.003). Reduced mitral annular plane systolic excursion (MAPSE) independently predicted left ventricular diastolic dysfunction in patients with chronic kidney disease (OR 0.39; 95% CI 0.21-0.74; p=0.003).
Synapse has enriched 10 related papers. Consider them for comparative context: